Eculizumab in chemotherapy-induced thrombotic microangiopathy

Thrombotic microangiopathy (TMA) is a rare but severe complication of tumors and their chemotherapeutic treatment. We report on two patients with chemotherapy-induced TMA who were successfully treated with a short course of the terminal complement inhibitor eculizumab. Both patients quickly achieved...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Nephrol Case Stud
Hlavní autoři: Schulte-Kemna, Lena, Reister, Barbara, Bettac, Lucas, Ludwig, Ulla, Fürst, Daniel, Mytilineos, Joannis, Bergmann, Carsten, van Erp, Rene, Schröppel, Bernd
Médium: Artigo
Jazyk:Inglês
Vydáno: Dustri-Verlag Dr. Karl Feistle 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171698/
https://ncbi.nlm.nih.gov/pubmed/32318323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS109836
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky